Xpert® MRSA NxG

Sign in to See Pricing
Image de produit

Xpert® MRSA NxG (10-test kit)

GXMRSA-NXG-10

Prix unitaire

Sous-total

Le produit n’est pas disponible à l’achat dans votre région.

Dispositifs de prélèvement

Image de produit

Dispositif de collecte (paquet de 50)

900-0370

Prix unitaire

Sous-total

Le produit n’est pas disponible à l’achat dans votre région.

Total

({{currency}})

0

Sign in to See Pricing

Ressources pour les produits

FAQ

1. What is Xpert® MRSA NxG test intended for?

1. What is Xpert® MRSA NxG test intended for?

Xpert MRSA NxG is a qualitative in vitro diagnostic test intended for the detection of methicillin-resistant Staphylococcus aureus (MRSA) DNA directly from nasal swabs in patients at risk for nasal colonization.1

2. How is the Xpert® MRSA NxG test performed?

2. How is the Xpert® MRSA NxG test performed?

Xpert® MRSA NxG utilizes automated real-time polymerase chain reaction (PCR) for the amplification of MRSA specific DNA targets and fluorogenic target-specific hybridization probes for the real-time detection of the amplified DNA. The Xpert MRSA NxG test is intended to aid in the prevention and control of MRSA infections in healthcare settings. 1

3. Is the Xpert MRSA NxG test intended to diagnose MRSA infections?

3. Is the Xpert MRSA NxG test intended to diagnose MRSA infections?

The Xpert MRSA NxG test is not intended to diagnose, guide, or monitor treatment for MRSA infections, or provide results of susceptibility to methicillin. A negative result does not preclude MRSA nasal colonization. Concomitant cultures are necessary to recover organisms for epidemiological typing or for further susceptibility testing. 1

4. What is Staphylococcus aureus (SA) and MRSA?

4. What is Staphylococcus aureus (SA) and MRSA?

Staphylococcus aureus (SA) is a human pathogen, which is the causative agent of a range of diseases including bacteremia, endocarditis, osteomyelitis, toxic shock syndrome, food poisoning, carbuncles, and boils.1 

In the early 1950s, acquisition and spread of beta-lactamase-producing plasmids thwarted the effectiveness of penicillin for treating SA infections. In 1959, methicillin, a semi-synthetic penicillin, was introduced and, soon after, methicillin-resistant SA (MRSA) strains were identified.1

Références :

 

 

1. Xpert® MRSA NxG Package Insert. 

Soutien à la clientèle

Access All of Your
Documents in MyCepheid

View and download documents associated with your tests and instruments

Login to MyCepheid

Find tests and collection devices, quickly add items to your cart, plan future orders, and checkout online at the Cepheid Store.

My Cepeid page
Can’t Find What
You’re Looking For?

View our self-help articles, create a case, or view contact information.

Scientist utilizing Cepheid lab in a cartridge test.
Powered by Translations.com GlobalLink Web SoftwarePowered by GlobalLink Web